In 2008, The Cancer Genome Atlas (TCGA) analysis of glioblastoma (GBM) revealed NF1 mutations or other alterations in approximately 20% of sporadic GBM, i.e. in patients without NF12. Here, NF1 is linked to glioblastoma.